- Report
- May 2026
- 197 Pages
Italy
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 198 Pages
Japan
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 199 Pages
Malaysia
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 200 Pages
Mexico
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 201 Pages
Netherlands
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 202 Pages
China
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 203 Pages
Saudi Arabia
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 204 Pages
South Africa
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 205 Pages
South Korea
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 207 Pages
Thailand
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 209 Pages
United Kingdom
From €4406EUR$4,850USD£3,803GBP
- Report
- April 2026
- 153 Pages
Canada
From €4406EUR$4,850USD£3,803GBP
- Report
- April 2026
- 179 Pages
China
From €4406EUR$4,850USD£3,803GBP
- Report
- April 2026
- 205 Pages
Germany
From €4406EUR$4,850USD£3,803GBP
- Report
- April 2026
- 231 Pages
India
From €4406EUR$4,850USD£3,803GBP
- Report
- June 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,803GBP
- Report
- September 2024
- 150 Pages
Global
From €4406EUR$4,850USD£3,803GBP
- Report
- February 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,803GBP
- Report
- November 2022
- 278 Pages
Global
From €3270EUR$3,600USD£2,823GBP

The Cancer Research market is a subset of the Drug Discovery market, focused on the development of treatments for cancer. This market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and government agencies. These stakeholders collaborate to develop new treatments and therapies for cancer, as well as to improve existing treatments. The market is driven by the need to find new and effective treatments for cancer, as well as to improve the quality of life for those affected by the disease.
The Cancer Research market is highly competitive, with many companies vying for a share of the market. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies are engaged in research and development of new treatments and therapies for cancer, as well as the marketing and distribution of existing treatments. Show Less Read more